These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 15907373)
21. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
22. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
23. Rapamycin limits formation of active eukaryotic initiation factor 4F complex following meal feeding in rat hearts. Vary TC; Deiter G; Lynch CJ J Nutr; 2007 Aug; 137(8):1857-62. PubMed ID: 17634255 [TBL] [Abstract][Full Text] [Related]
24. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition. Dudkin L; Dilling MB; Cheshire PJ; Harwood FC; Hollingshead M; Arbuck SG; Travis R; Sausville EA; Houghton PJ Clin Cancer Res; 2001 Jun; 7(6):1758-64. PubMed ID: 11410517 [TBL] [Abstract][Full Text] [Related]
25. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E). Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of mammalian target of rapamycin (mTOR) signalling in C2C12 myoblasts prevents myogenic differentiation without affecting the hyperphosphorylation of 4E-BP1. Willett M; Cowan JL; Vlasak M; Coldwell MJ; Morley SJ Cell Signal; 2009 Oct; 21(10):1504-12. PubMed ID: 19481146 [TBL] [Abstract][Full Text] [Related]
27. Alcohol impairs leucine-mediated phosphorylation of 4E-BP1, S6K1, eIF4G, and mTOR in skeletal muscle. Lang CH; Frost RA; Deshpande N; Kumar V; Vary TC; Jefferson LS; Kimball SR Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1205-15. PubMed ID: 12944322 [TBL] [Abstract][Full Text] [Related]
28. Suppression of translation during in vitro maturation of pig oocytes despite enhanced formation of cap-binding protein complex eIF4F and 4E-BP1 hyperphosphorylation. Ellederova Z; Kovarova H; Melo-Sterza F; Livingstone M; Tomek W; Kubelka M Mol Reprod Dev; 2006 Jan; 73(1):68-76. PubMed ID: 16211600 [TBL] [Abstract][Full Text] [Related]
29. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Lang CH; Frost RA Metabolism; 2007 Jan; 56(1):49-57. PubMed ID: 17161226 [TBL] [Abstract][Full Text] [Related]
30. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663 [TBL] [Abstract][Full Text] [Related]
31. Manipulation of the host translation initiation complex eIF4F by DNA viruses. Walsh D Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117 [TBL] [Abstract][Full Text] [Related]
32. Rapamycin-sensitive induction of eukaryotic initiation factor 4F in regenerating mouse liver. Goggin MM; Nelsen CJ; Kimball SR; Jefferson LS; Morley SJ; Albrecht JH Hepatology; 2004 Sep; 40(3):537-44. PubMed ID: 15349891 [TBL] [Abstract][Full Text] [Related]
33. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Zhou L; Goldsmith AM; Bentley JK; Jia Y; Rodriguez ML; Abe MK; Fingar DC; Hershenson MB Am J Respir Cell Mol Biol; 2005 Aug; 33(2):195-202. PubMed ID: 15901615 [TBL] [Abstract][Full Text] [Related]
34. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model. Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861 [TBL] [Abstract][Full Text] [Related]
35. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912 [TBL] [Abstract][Full Text] [Related]
36. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128 [TBL] [Abstract][Full Text] [Related]
37. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859 [TBL] [Abstract][Full Text] [Related]
38. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. Lang CH; Frost RA J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631 [TBL] [Abstract][Full Text] [Related]
39. Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells. Quevedo C; Salinas M; Alcázar A Biochem Biophys Res Commun; 2002 Mar; 291(3):560-6. PubMed ID: 11855825 [TBL] [Abstract][Full Text] [Related]
40. L-serine deficiency caused by genetic Phgdh deletion leads to robust induction of 4E-BP1 and subsequent repression of translation initiation in the developing central nervous system. Sayano T; Kawakami Y; Kusada W; Suzuki T; Kawano Y; Watanabe A; Takashima K; Arimoto Y; Esaki K; Wada A; Yoshizawa F; Watanabe M; Okamoto M; Hirabayashi Y; Furuya S FEBS J; 2013 Mar; 280(6):1502-17. PubMed ID: 23350942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]